Dimerix enters licensing deal with Everest Medicines
Dimerix (ASX:DXB) executed a licensing agreement with Everest Medicines to develop and commercialise its clinical-stage drug candidate, DMX-200.
Dimerix (ASX:DXB) executed a licensing agreement with Everest Medicines to develop and commercialise its clinical-stage drug candidate, DMX-200.
Standard Chartered expects assets locked in decentralised finance to increase to US$2.7 trillion by the end of 2030, representing a 37-fold rise from current levels.
Bitcoin Policy UK CEO Susie Ward criticised Strategy Executive Chairman Michael Saylor's promotion of the company's STRC preferred shares, arguing that the investment's risks were not adequately disclosed.
Official Trump (CRYPTO:TRUMP) fell 2.6% over the past 24 hours to a market capitalisation of US$477 million as traders assessed whether the token could maintain its recent breakout.
Karoon Energy (ASX:KAR) has reduced its 2026 total production guidance to a range of 7.2 to 8.2 million barrels of oil equivalent.
Bitcoin (CRYPTO:BTC) climbed nearly 4% to around US$67,000 as reports of a US-Iran ceasefire boosted risk appetite and supported gains across cryptocurrency and crypto-linked equities.
Delta Lithium (ASX:DLI) has executed an agreement to acquire tenements at its Yinnetharra project from Reach Resources (ASX:RR1) for $800,000.
Binance launched its equities trading platform for eligible non-US users on June 1 and recorded more than US$1 billion in trading volume during its first nine trading days.
Dart Mining (ASX:DTM) has executed a binding sale and purchase deed to divest four of its exploration projects to Indigo Metals.
A wallet reportedly linked to BitMEX co-founder Arthur Hayes received 3,000 Ethereum (CRYPTO:ETH) worth approximately US$5.42 million as the cryptocurrency climbed nearly 6% in 24 hours.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy